6,000
Participants
Start Date
May 30, 2018
Primary Completion Date
October 30, 2019
Study Completion Date
November 28, 2019
Gardasil® [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant vaccine]
HPV vaccination in an alternative schedule for MSM of 1 dose (M0).
Two dose
HPV vaccination in an alternative schedule for MSM of 2 doses over a 6-month period (M0,6)
Control group
HPV vaccination at 12 months
2 dose vaccination over 6 month
2-dose HPV vaccination regimen over a 6-month period (M0,6)
Instituto Nacional de Salud Publica, Cuernavaca
Universidad Nacional Autonoma de Mexico
OTHER
National Council of Science and Technology, Mexico
OTHER
Instituto Nacional de Salud Publica, Mexico
OTHER